文献速递前列腺癌

基因组数据库中前列腺特异性膜抗原(PSMA/FOLH1)表达的预测因素

Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
PubMed 文献 · Urology · 2020-06-30

本研究基于Decipher Biosciences基因组数据库,纳入16807例接受根治性前列腺切除术的前列腺癌患者,分析FOLH1(PSMA)表达与Gleason分级分组、Decipher风险分类、基底/管腔分子亚型及雄激素受体活性的关联。结果显示,除Gleason分级5组外,较高分级分组与较高PSMA表达相关;管腔亚型PSMA表达显著高于基底亚型(1.01 vs 0.68,P<.001);多变量模型中管腔亚型、高雄激素受体活性评分及高分级分组与较高FOLH1百分位排名显著相关(P<.001)。

要点

  • 较高Gleason分级分组(除5组外)与较高PSMA表达相关。
  • 管腔亚型PSMA表达显著高于基底亚型。
  • 管腔亚型、高雄激素受体活性及高分级分组独立预测高FOLH1表达。

核心结论

  • 高PSMA(FOLH1)表达与高雄激素受体活性和管腔亚型相关。
  • 基因组检测可能有助于预测、解读和/或指导PSMA诊疗一体化。

研究设计与样本

  • 回顾性分析Decipher Biosciences去标识基因组数据库。
  • 纳入16807例接受根治性前列腺切除术并接受Decipher检测的前列腺癌患者,平均年龄65岁。
  • 大多数患者为Gleason分级分组2(35%)或3(27%)。

主要发现

  • Gleason分级分组1、2、3、4、5的PSMA表达分别为0.66、0.84、0.99、1.07、0.99(P<.001)。
  • 管腔亚型PSMA表达为1.01,基底亚型为0.68(P<.001)。
  • 雄激素受体活性特征在基底亚型为0.19,管腔亚型为0.62(P<.001)。
  • 多变量模型中,管腔亚型、高雄激素受体活性评分和高Gleason分级分组与较高FOLH1百分位排名显著相关(P<.001)。

临床怎么用

  • 对于管腔亚型或高雄激素受体活性的前列腺癌患者,PSMA表达可能更高,可考虑PSMA靶向成像或治疗。
  • 基因组检测结果可能辅助解读PSMA PET结果或指导PSMA诊疗一体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess predictors of prostate-specific membrane antigen (PSMA) expression in a genomic database; positron emission tomography with PSMA-targeted radiopharmaceuticals is increasingly being utilized. METHODS: The de-identified Decipher Biosciences database, which includes expression for more than 46,000 coding and noncoding genes per patient, was queried for expression of FOLH1 (PSMA). Prostate cancer patients who underwent radical prostatectomy and received the Decipher Test were included in the analysis. PSMA expression was compared to the Gleason Grade Group, Decipher risk category (a validated 22 biomarker genomic score), basal versus luminal molecular subtype, and androgen receptor activity. Multivariable regression analyses were performed. RESULTS: The Decipher de-identified Decipher Biosciences database contained 16,807 men who underwent prostatectomy with the average age being 65-year old and most being Gleason Grade Group 2 (35%) or 3 (27%). Higher Grade Group was associated with higher PSMA expression except in Grade Group 5 [Grade group: 1 (0.66), 2 (0.84), 3 (0.99), 4 (1.07), 5 (0.99), P <.001]. Luminal subtype was found to have much higher PSMA expression when compared to basal (1.01 vs 0.68, P <.001). The androgen receptor activity signature demonstrated a dramatic difference between basal (0.19) and luminal (0.62) subtypes (P <.001). In the multivariable model, luminal patients, high androgen receptor activity scores, and high Grade Groups were significantly associated with higher FOLH1 percentile rank (P <.001). CONCLUSION: High PSMA expression (FOLH1) was associated with high androgen receptor activity and luminal subtype. Genomic tests could aid in predicting, interpreting, and/or directing PSMA theranostics.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Bahler CD, Johnson MM, Davicioni E, et al. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database. Urology. 2020. PMID: 32619596. doi:10.1016/j.urology.2020.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。